Osaic Holdings
FMED icon

Osaic Holdings’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Osaic Holdings’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25K Buy
+114
New +$2.89K ﹤0.01% 7110

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Osaic Holdings's FMED Position: Q2 2026 in Review

Osaic Holdings opened a new position in Fidelity Disruptive Medicine ETF (FMED) in Q2 2026: 114 shares worth $3.25K. The stake represents ﹤0.01% of the portfolio and ranks #7110 among its holdings.

11 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Osaic Holdings held 114 shares of Fidelity Disruptive Medicine ETF worth $3.25K as of Q2 2026.
  • Fidelity Disruptive Medicine ETF was a new Osaic Holdings position in Q2 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7110 holding.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.